CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report

Dong-Wan KimSang-We KimD. Ross CamidgeCatherine A. ShuKristen A. MarroneXiuning LeCollin M. BlakelyKeunchil ParkGee-Chen ChangSandip Pravin PatelGozde KarZachary A. CooperRamin SamadaniMichael PlutaRakesh KumarSuresh Ramalingam2026-02-032026-02-032023-0510.1016/j.jtho.2022.12.021https://scholars.csmu.edu.tw/handle/123456789/4739[SDGs]SDG3CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Reportjournal-article